Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 11;12(1):7778.
doi: 10.1038/s41598-022-12034-6.

Late non-fasting plasma glucose predicts cardiovascular mortality independent of hemoglobin A1c

Affiliations

Late non-fasting plasma glucose predicts cardiovascular mortality independent of hemoglobin A1c

Yutang Wang et al. Sci Rep. .

Abstract

It is unknown whether non-fasting plasma glucose (PG) is associated with cardiovascular disease (CVD) mortality. This study aimed to investigate this association in US adults. This study included adults from the National Health and Nutrition Examination Surveys from 1988 to 2014. Mortality outcomes were ascertained by linkage to the National Death Index records. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) of PG for CVD mortality. Among 34,907 participants, 1956, 5564, and 27,387 had PG from participants in early non-fasting, late non-fasting, and fasting states, respectively (defined as a period since last calorie intake of 0-2.9, 3.0-7.9, or ≥ 8.0 h, respectively). This cohort was followed up for 455,177 person-years (mean follow-up, 13.0 years), with 2,387 CVD deaths being recorded. After adjustment for all confounders including hemoglobin A1c (HbA1c), only late non-fasting PG (continuous, natural log-transformed) was positively associated with CVD mortality risks (hazard ratio, 1.73; 95% confidence interval 1.12-2.67). Higher late non-fasting PG (dichotomous, at a cut-off of 105, 110, or 115 mg/dL) was associated with higher CVD mortality risks. In addition, at the cut-off of 115 mg/dL, higher late non-fasting PG was associated with higher CVD mortality risks in those with either a normal (< 5.7%) or prediabetic HbA1c level (from 5.7 to 6.4%). In conclusion, late non-fasting PG predicts CVD mortality independent of HbA1c. Late non-fasting PG with a cut-off of 115 mg/dL may be used to identify those at high CVD risk.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Mean plasma glucose concentrations at each hour since the last caloric intake. The line graph represents plasma glucose concentrations, and the histogram represents sample size at each time point. The time since the last caloric intake was divided into three periods: 0–2.9 h (early non-fasting), 3.0–7.9 h (late non-fasting), and ≥ 8.0 h (fasting). NF, non-fasting.

Similar articles

Cited by

References

    1. Meigs JB, Nathan DM, D’Agostino RB, Wilson PWF. Fasting and postchallenge glycemia and cardiovascular disease risk: The Framingham Offspring Study. Diabetes Care. 2002;25:1845–1850. doi: 10.2337/diacare.25.10.1845. - DOI - PubMed
    1. Brunner EJ, Shipley MJ, Witte DR, Fuller JH, Marmot MG. Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study. Diabetes Care. 2006;29:26–31. doi: 10.2337/diacare.29.01.06.dc05-1405. - DOI - PubMed
    1. Barr EL, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) Circulation. 2007;116:151–157. doi: 10.1161/CIRCULATIONAHA.106.685628. - DOI - PubMed
    1. Arnett DK, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2019;74:e177–e232. doi: 10.1016/j.jacc.2019.03.010. - DOI - PMC - PubMed
    1. American Diabetes Association 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes—2021. Diabetes Care. 2021;44:S15–S33. doi: 10.2337/dc21-S002. - DOI - PubMed